Taysha Gene Therapies, Inc. TSHA Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s net change in cash?
- Taysha Gene Therapies, Inc. (TSHA) reported net change in cash of -$43.19M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s net change in cash changed year-over-year?
- Taysha Gene Therapies, Inc.'s net change in cash decreased by 92.4% year-over-year, from -$22.44M to -$43.19M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s net change in cash?
- Over 2 years (2021 to 2025), Taysha Gene Therapies, Inc.'s net change in cash has grown at a 40.5% compound annual growth rate (CAGR), from -$99.51M to $196.31M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.